Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.
|Original language||English (US)|
|Number of pages||2|
|Journal||Annals of internal medicine|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Internal Medicine